Sentences with phrase «by macular»

She continued to create new work in her 80s and 90s, even while affected by macular degeneration.

A lifelong reader who grew up in a home in industrial South Wales with few books, Mary calls her iPad her «best friend» and reflects how before the digital age her reading life would have been cut short by macular degeneration.

With courage and determination, Susan navigated major obstacles imposed by macular degeneration throughout her adult life.

Our research is funded by the Macular Degeneration Research Foundation; this is under the umbrella of the BrightFocus Foundation.

This research has the first steps, and that research was also funded by the Macular Degeneration Research Fund at BrightFocus.

Among her reasons for leaving, Aquila said, was the fact that her ability to read large amounts of material has been hampered by macular degeneration.

Not exact matches

Studies show that lutein and zeaxanthin can benefit eye health by decreasing the risk of cataracts and age - related macular degeneration, two common causes of vision loss in older adults (36).

This vegetable also has Zea - xanthin which helps protect eyes from «age - related macular disease» (ARMD) in the elderly persons by filtering harmful ultra-violet rays.

Recipe from Eat Right For Your Sight: Simple Tasty Recipes That Help Reduce the Risk of Vision Loss from Macular Degeneration, By Jennifer Trainer Thompson and Johanna M. Seddon, copyright © American Macular Degeneration Foundation, 2014.

The high - energy blue light from digital devices is responsible for eye strain, bleary eyes by midafternoon, poor sleep patterns — even a younger age at which blindness hits because of age - related macular degeneration.

My grandmother takes lutein and zinc prescribed by her MD in the hopes it will slow her macular degeneration.

Emerging technologies successfully stimulate retinas ravaged by retinitis pigmentosa, age - related macular degeneration and other diseases to give sufferers a new lease on light

Patients with age - related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published online by JAMA Ophthalmology.

Then she moved to her current position as principal scientist of a group that studies Alzheimer's disease and age - related macular degeneration at San Francisco's Rinat Laboratories, which is owned by Pfizer.

The device can treat either form of age - related macular degeneration: the dry stage, where the delicate tissues of the macula become thinned and slowly lose function, or the less common wet stage that's caused by the growth of abnormal blood vessels behind the macula.

New devices provide hope of stopping and reversing damage caused by age - related macular degeneration

Those suffering from advanced stages of macular degeneration may by the end of this year be able to halt and even reverse vision loss caused by the age - related eye disease.

Cataract was the next main cause in this region, with 15.5 %, followed by age - related macular degeneration.

«Retinal implant designed to replace support cells damaged by dry age - related macular degeneration.»

The new drug, in its time - release coating, was tested in mice with abnormalities similar to those experienced by people with neovascular age - related macular degeneration, or «wet» AMD.

The results could eventually be relevant to the treatment of a much more common cause of blindness, age - related macular degeneration, which is caused by whole host of faulty genes.

Their results could be relevant to the treatment of a more common cause of blindness, age - related macular degeneration, which is caused by a host of faulty genes.

Approximately 25 percent of eyes deemed to be normal based on dilated eye examination by a primary eye care ophthalmologist or optometrist had macular characteristics that indicated age - related macular degeneration, according to a study published by JAMA Ophthalmology.

David C. Neely, M.D., of the University of Alabama at Birmingham Department of Ophthalmology, and colleagues conducted a study that included 644 people 60 years or older with normal macular health per medical record based on their most recent dilated comprehensive eye examination by a primary eye care ophthalmologist or optometrist.

Many diseases that lead to blindness, such as glaucoma and macular degeneration, are caused by the death of certain cells in the human retina that lack the ability to regenerate.

Macular degeneration gradually diminishes vision by damaging the macula, an oval - shaped yellow spot located in the center of the retina.

«Their increased risk for age - related diseases in general led us to analyze how these patients are impacted by one of the most common age - related eye diseases, macular degeneration.»

It has been designed for treating the «dry» form of macular degeneration, caused by deposits on the retina gradually killing retinal pigment epithelial cells, which support light - capturing cells.

In a second trial starting around the same time, a different team in Zhengzhou will use ES cells to target vision loss caused by age - related macular degeneration.

An estimated 2 million people in the United States suffer from age - related macular degeneration, with the incidence expected to rise to 3.5 million by 2030 and to 5.5 million by 2050.

Roughly 20 percent of patients with age - related macular degeneration suffer from abnormal blood vessel growth and vascular leakage, says Campochiaro, and so may be helped by this new therapy, if it proves to work in clinical trials.

In 1997, the mainstays of therapy for patients with macular degeneration include daily monitoring of the integrity of their central vision (usually by viewing a simple printed grid) as well as periodic visits to their eye doctor.

When a disease like macular degeneration is caused by a dominant gene, a number of family members may be similarly affected.

In the second study, a team led by Anand Swaroop, a molecular geneticist at the National Eye Institute in Bethesda, Maryland, confirmed the same link between macular degeneration and LIPC.

Unlike some other common vision disorders, such as age - related macular degneration, color blindness is a heritable disorder caused by a single gene that is defective or absent.

Born with retinoschisis, a rare disease akin to macular degeneration, Erik Weihenmayer was sightless by age 13.

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost - effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.

In the article, «Utility of Hard Exudates for the Screening of Macular Edema,» using digital photographs of the eye taken at the doctor's office or clinic, eye specialists can reliably detect «hard exudates» — a key early sign of diabetes - related macular edema, reports the new research by Jorge A. Cuadros, OD, PhD, of UC Berkeley School of Optometry and collMacular Edema,» using digital photographs of the eye taken at the doctor's office or clinic, eye specialists can reliably detect «hard exudates» — a key early sign of diabetes - related macular edema, reports the new research by Jorge A. Cuadros, OD, PhD, of UC Berkeley School of Optometry and collmacular edema, reports the new research by Jorge A. Cuadros, OD, PhD, of UC Berkeley School of Optometry and colleagues.

The photos were sent over the Internet for review by eye specialists, who looked for hard exudates close to the line of sight as an indicator of clinically significant macular edema.

Age - related macular degeneration affects approximately 1.7 million Americans and is projected to rise to almost 3 million by 2020.

The study, «Photosensitivity of Neurons Enabled by Cell - Targeted Gold Nanoparticles,» was supported by the National Institutes of Health, Beckman Initiative for Macular Research and Research to Prevent Blindness.

According to the National Eye Institute, age - related macular degeneration affects more than 1.75 million Americans, a number that is expected to increase to almost 3 million by 2020 due to the aging of the U.S. population.

SALT LAKE CITY — Two major eye diseases and leading causes of blindness — age - related macular degeneration and diabetic retinopathy — can be reversed or even prevented by drugs that activate a protein found in...

This research points to exciting new possibilities for preventing or reversing the disabling vision loss caused by age - related macular degeneration, diabetic retinopathy, retinitis pigmentosa, glaucoma, and other diseases that damage the retina, the layer of light - sensitive nerve cells that line the back of the eye.

A team led by Steven Schwartz at UCLA administered about 50,000 cells Tuesday into one eye of a volunteer suffering from Stargardt Macular Dystrophy, a progressive form of blindness that usually begins in childhood, and another with Dry Age - Related Macular Degeneration, the leading cause of blindness in the developed world, Advanced Cell Technology, which is sponsoring the study, announced Thursday.

The elderly woman, who had macular degeneration, thought she was paying to participate in a clinical trial that would save her sight by injecting stem cells into both eyes.

Guided by the recommendations of our Macular Degeneration Research Scientific Review Committee, we are pleased to announce $ 2.6 million for 17 new macular degeneration research Macular Degeneration Research Scientific Review Committee, we are pleased to announce $ 2.6 million for 17 new macular degeneration research macular degeneration research grants.

These findings suggest that RPE cells, derived from iPS cells, could be used to treat blindness in humans, such as blindness caused by age - related macular degeneration, a leading cause of blindness in the Western world.

A trial being conducted by Advanced Cell Technology is testing the effectiveness of MA09 - hRPE, human ESCs terminally differentiated into retinal pigment epithelial (RPE) cells, in treating degenerative macular diseases.

The Argus II will help people blinded by the rare hereditary disease retinitis pigmentosa or seniors suffering from severe macular degeneration.